KRAS and acute lymphoblastic leukemia: To explore the potential impacts of RAS pathway mutations in B-ALL, we expressed a canonical hotspot KRAS-G12D mutation (henceforth referred to “RASmt”) or an empty vector (“Ctrl” in text) in the human B-ALL cell line Reh.